The world is our lab.

ALS Research Toolkit

Everything we do supports our mission of finding treatments and a cure for ALS, which is why it is so critical to fund outstanding ALS research. We have the premier ALS research program in the world.

Our approach is simple and has led to some of the biggest research discoveries in the history of ALS. We fund the best, most promising research around the globe, while inspiring... and initiating innovative partnerships across all sectors – government, industry, academia, and other nonprofit organizations – while funding bright, young scientists to spur innovation.

Thanks to the donations raised during the ALS Ice Bucket Challenge, we are now spending three times more than on ALS research than before summer 2014. Click the button below to download the ALS Research Toolkit and learn more about our global research program.

Lawrence and Isabel Barnett Drug Development Program

Our Lawrence and Isabel Barnett Drug Development Program allows us the freedom to strategically fund preclinical projects aimed at developing therapeutics for ALS that are product-driven. It is anticipated that the agents and/or data generated from these funded projects will lead to the advancement of new therapies for ALS.

This vital program is named in honor of Lawrence and Isabel Barnett, who contributed their time, talent and treasure to The ALS Association after a family friend was diagnosed with the disease. Their commitment to the fight against ALS helped enable tremendous progress in understanding the disease through groundbreaking research.

Making a global impact

“

With The ALS Association’s ongoing support, my work in antisense technology, which was once thought of as innovative and risky, has led to clinical trials that could help people with ALS and other neurodegenerative diseases.

Don Cleveland, Ph.D.
University of California at San Diego
Elected Member, National Academy of Sciences

Participate in clinical trials

Funding global research

“

ALS Association-funded scientists are currently active in more than 11 countries around the world. We are grateful for our donors who make this global approach possible, getting us closer to our ultimate goal, a world without ALS.